The reimbursed pharmaceutical market for generics in Germany stood at 27 in 2023. The forecasted data for the following years show a downward trend, with values expected to decrease progressively from 27 in 2024 to 25.6 by 2028. Year-on-year variations indicate a decline of approximately 1.48% in 2025, 1.50% in 2026, 1.15% in 2027, and 1.16% in 2028. The Compound Annual Growth Rate (CAGR) over the five-year period from 2024 to 2028 is approximately -1.3%, signifying a steady, moderate decline in market value.
Future trends to watch for include the potential impact of new healthcare policies, changes in government reimbursement rates, increased competition from biosimilars, and evolving preferences of healthcare providers towards cost-effective treatment alternatives. Additionally, advancements in technology and new drug approvals may also influence market dynamics.
